 | • レポートコード：GIR-107A12621 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、前立腺がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前立腺がん治療薬の種類別市場規模（LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬）、用途別市場規模（55歳以下、55〜75歳、75歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・前立腺がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca plc、Active Biotech、Bristol Myers-Squibb、Teva Pharmaceuticals Industries Ltd.、Johnson & Johnson、Pfizer Inc.、Bayer AG、Abbott Laboratories、Astellas Pharma Inc.、Roche Holding AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬 ・用途別分析2016年-2026年：55歳以下、55〜75歳、75歳以上 ・前立腺がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・前立腺がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・前立腺がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・前立腺がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・前立腺がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prostate Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prostate Cancer Medicine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostate Cancer Medicine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prostate Cancer Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Market segment by Application, can be divided into
Age Below 55
Age 55-75
Age Above 75
Market segment by players, this report covers
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer Medicine, with revenue, gross margin and global market share of Prostate Cancer Medicine from 2019 to 2021.
Chapter 3, the Prostate Cancer Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostate Cancer Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prostate Cancer Medicine research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer Medicine
1.2 Classification of Prostate Cancer Medicine by Type
1.2.1 Overview: Global Prostate Cancer Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate Cancer Medicine Revenue Market Share by Type in 2020
1.2.3 LHRH Antagonists
1.2.4 LHRH Analogs
1.2.5 Antiandrogens
1.2.6 Pipeline Drugs for Hormonal Therapy
1.3 Global Prostate Cancer Medicine Market by Application
1.3.1 Overview: Global Prostate Cancer Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Global Prostate Cancer Medicine Market Size & Forecast
1.5 Global Prostate Cancer Medicine Market Size and Forecast by Region
1.5.1 Global Prostate Cancer Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate Cancer Medicine Market Size by Region, (2016-2021)
1.5.3 North America Prostate Cancer Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate Cancer Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate Cancer Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Prostate Cancer Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate Cancer Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Medicine Market Drivers
1.6.2 Prostate Cancer Medicine Market Restraints
1.6.3 Prostate Cancer Medicine Trends Analysis
2 Company Profiles
2.1 AstraZeneca plc
2.1.1 AstraZeneca plc Details
2.1.2 AstraZeneca plc Major Business
2.1.3 AstraZeneca plc Prostate Cancer Medicine Product and Solutions
2.1.4 AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca plc Recent Developments and Future Plans
2.2 Active Biotech
2.2.1 Active Biotech Details
2.2.2 Active Biotech Major Business
2.2.3 Active Biotech Prostate Cancer Medicine Product and Solutions
2.2.4 Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Active Biotech Recent Developments and Future Plans
2.3 Bristol Myers-Squibb
2.3.1 Bristol Myers-Squibb Details
2.3.2 Bristol Myers-Squibb Major Business
2.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Product and Solutions
2.3.4 Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol Myers-Squibb Recent Developments and Future Plans
2.4 Teva Pharmaceuticals Industries Ltd.
2.4.1 Teva Pharmaceuticals Industries Ltd. Details
2.4.2 Teva Pharmaceuticals Industries Ltd. Major Business
2.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product and Solutions
2.4.4 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Teva Pharmaceuticals Industries Ltd. Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Prostate Cancer Medicine Product and Solutions
2.5.4 Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Prostate Cancer Medicine Product and Solutions
2.6.4 Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pfizer Inc. Recent Developments and Future Plans
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Prostate Cancer Medicine Product and Solutions
2.7.4 Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bayer AG Recent Developments and Future Plans
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Prostate Cancer Medicine Product and Solutions
2.8.4 Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Abbott Laboratories Recent Developments and Future Plans
2.9 Astellas Pharma Inc.
2.9.1 Astellas Pharma Inc. Details
2.9.2 Astellas Pharma Inc. Major Business
2.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Product and Solutions
2.9.4 Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Prostate Cancer Medicine Product and Solutions
2.10.4 Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche Holding AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate Cancer Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Cancer Medicine Players Market Share
3.2.2 Top 10 Prostate Cancer Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate Cancer Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate Cancer Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate Cancer Medicine Revenue Market Share by Application (2016-2021)
5.2 Prostate Cancer Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate Cancer Medicine Revenue by Type (2016-2026)
6.2 North America Prostate Cancer Medicine Revenue by Application (2016-2026)
6.3 North America Prostate Cancer Medicine Market Size by Country
6.3.1 North America Prostate Cancer Medicine Revenue by Country (2016-2026)
6.3.2 United States Prostate Cancer Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate Cancer Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate Cancer Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Cancer Medicine Revenue by Type (2016-2026)
7.2 Europe Prostate Cancer Medicine Revenue by Application (2016-2026)
7.3 Europe Prostate Cancer Medicine Market Size by Country
7.3.1 Europe Prostate Cancer Medicine Revenue by Country (2016-2026)
7.3.2 Germany Prostate Cancer Medicine Market Size and Forecast (2016-2026)
7.3.3 France Prostate Cancer Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate Cancer Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate Cancer Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Cancer Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate Cancer Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Medicine Revenue by Region (2016-2026)
8.3.2 China Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8.3.5 India Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate Cancer Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate Cancer Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate Cancer Medicine Revenue by Type (2016-2026)
9.2 South America Prostate Cancer Medicine Revenue by Application (2016-2026)
9.3 South America Prostate Cancer Medicine Market Size by Country
9.3.1 South America Prostate Cancer Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Prostate Cancer Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate Cancer Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Cancer Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate Cancer Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Prostate Cancer Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate Cancer Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate Cancer Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prostate Cancer Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate Cancer Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate Cancer Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate Cancer Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate Cancer Medicine Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca plc Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca plc Major Business
Table 8. AstraZeneca plc Prostate Cancer Medicine Product and Solutions
Table 9. AstraZeneca plc Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Active Biotech Corporate Information, Head Office, and Major Competitors
Table 11. Active Biotech Major Business
Table 12. Active Biotech Prostate Cancer Medicine Product and Solutions
Table 13. Active Biotech Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol Myers-Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol Myers-Squibb Major Business
Table 16. Bristol Myers-Squibb Prostate Cancer Medicine Product and Solutions
Table 17. Bristol Myers-Squibb Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Teva Pharmaceuticals Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. Teva Pharmaceuticals Industries Ltd. Major Business
Table 20. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product and Solutions
Table 21. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Prostate Cancer Medicine Product and Solutions
Table 25. Johnson & Johnson Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Inc. Major Business
Table 28. Pfizer Inc. Prostate Cancer Medicine Product and Solutions
Table 29. Pfizer Inc. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 31. Bayer AG Major Business
Table 32. Bayer AG Prostate Cancer Medicine Product and Solutions
Table 33. Bayer AG Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Abbott Laboratories Major Business
Table 36. Abbott Laboratories Prostate Cancer Medicine Product and Solutions
Table 37. Abbott Laboratories Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Astellas Pharma Inc. Major Business
Table 40. Astellas Pharma Inc. Prostate Cancer Medicine Product and Solutions
Table 41. Astellas Pharma Inc. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 43. Roche Holding AG Major Business
Table 44. Roche Holding AG Prostate Cancer Medicine Product and Solutions
Table 45. Roche Holding AG Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Prostate Cancer Medicine Revenue (USD Million) by Players (2019-2021)
Table 47. Global Prostate Cancer Medicine Revenue Share by Players (2019-2021)
Table 48. Breakdown of Prostate Cancer Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Prostate Cancer Medicine Players Head Office, Products and Services Provided
Table 50. Prostate Cancer Medicine Mergers & Acquisitions in the Past Five Years
Table 51. Prostate Cancer Medicine New Entrants and Expansion Plans
Table 52. Global Prostate Cancer Medicine Revenue (USD Million) by Type (2016-2021)
Table 53. Global Prostate Cancer Medicine Revenue Share by Type (2016-2021)
Table 54. Global Prostate Cancer Medicine Revenue Forecast by Type (2021-2026)
Table 55. Global Prostate Cancer Medicine Revenue by Application (2016-2021)
Table 56. Global Prostate Cancer Medicine Revenue Forecast by Application (2021-2026)
Table 57. North America Prostate Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Prostate Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Prostate Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Prostate Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Prostate Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Prostate Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Prostate Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Prostate Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Prostate Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Prostate Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Prostate Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Prostate Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Prostate Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Prostate Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Prostate Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Prostate Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Prostate Cancer Medicine Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Prostate Cancer Medicine Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Prostate Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Prostate Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Prostate Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Prostate Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Prostate Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Prostate Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Prostate Cancer Medicine Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Prostate Cancer Medicine Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Prostate Cancer Medicine Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Prostate Cancer Medicine Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Prostate Cancer Medicine Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Prostate Cancer Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate Cancer Medicine Picture
Figure 2. Global Prostate Cancer Medicine Revenue Market Share by Type in 2020
Figure 3. LHRH Antagonists
Figure 4. LHRH Analogs
Figure 5. Antiandrogens
Figure 6. Pipeline Drugs for Hormonal Therapy
Figure 7. Prostate Cancer Medicine Revenue Market Share by Application in 2020
Figure 8. Age Below 55 Picture
Figure 9. Age 55-75 Picture
Figure 10. Age Above 75 Picture
Figure 11. Global Prostate Cancer Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Prostate Cancer Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Prostate Cancer Medicine Revenue Market Share by Region (2016-2026)
Figure 14. Global Prostate Cancer Medicine Revenue Market Share by Region in 2020
Figure 15. North America Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prostate Cancer Medicine Market Drivers
Figure 21. Prostate Cancer Medicine Market Restraints
Figure 22. Prostate Cancer Medicine Market Trends
Figure 23. AstraZeneca plc Recent Developments and Future Plans
Figure 24. Active Biotech Recent Developments and Future Plans
Figure 25. Bristol Myers-Squibb Recent Developments and Future Plans
Figure 26. Teva Pharmaceuticals Industries Ltd. Recent Developments and Future Plans
Figure 27. Johnson & Johnson Recent Developments and Future Plans
Figure 28. Pfizer Inc. Recent Developments and Future Plans
Figure 29. Bayer AG Recent Developments and Future Plans
Figure 30. Abbott Laboratories Recent Developments and Future Plans
Figure 31. Astellas Pharma Inc. Recent Developments and Future Plans
Figure 32. Roche Holding AG Recent Developments and Future Plans
Figure 33. Global Prostate Cancer Medicine Revenue Share by Players in 2020
Figure 34. Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Prostate Cancer Medicine Revenue Market Share in 2020
Figure 36. Global Top 10 Players Prostate Cancer Medicine Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Prostate Cancer Medicine Revenue Share by Type in 2020
Figure 39. Global Prostate Cancer Medicine Market Share Forecast by Type (2021-2026)
Figure 40. Global Prostate Cancer Medicine Revenue Share by Application in 2020
Figure 41. Global Prostate Cancer Medicine Market Share Forecast by Application (2021-2026)
Figure 42. North America Prostate Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 43. North America Prostate Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 44. North America Prostate Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 45. United States Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Prostate Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 49. Europe Prostate Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 50. Europe Prostate Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 51. Germany Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Prostate Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Prostate Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Region (2016-2026)
Figure 59. China Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Prostate Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 66. South America Prostate Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 67. South America Prostate Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Prostate Cancer Medicine Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Prostate Cancer Medicine Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Prostate Cancer Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の前立腺がん診断市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界の個別化がん治療市場 2021：企業別、地域別、種類・用途別 The Personalized Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の乳がん用HER-2標的薬市場 2021：企業別、地域別、種類・用途別 The HER-2 Targeted Drugs for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の乳がん用VEGF標的薬市場 2021：企業別、地域別、種類・用途別 The VEGF Targeted Drugs for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の腫瘍プレシジョンメディシン市場 2021：企業別、地域別、種類・用途別 The Oncology Precision Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…